Trial of Yellow Fever Inactivated Vaccine

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

October 31, 2010

Conditions

Yellow Fever

Interventions

BIOLOGICAL

XRX-001 Inactivated yellow fever vaccine

Inactivated yellow fever vaccine, alum adsorbed, High dose = 2.3 x 10\^8 VE/0.5mL and Mid dose = 2.2 x 10\^7 VE/0.5mL

BIOLOGICAL

Placebo

NaCl Injectable 0.9%

Trial Locations (1)

Johnson County Clin-Trials, Lenexa